{"transactions":[{"id":725583,"issuer":{"id":3826,"kind":"organization","name":"Stevanato Group S.p.A."},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-26T10:05:44.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":1493,"price":17.09,"value":25515.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents ordinary shares sold by the Reporting Person to cover tax obligations associated with the grant of ordinary shares."}],"balance_after":5757,"source":{"system":"sec-edgar","filing":"0001193125-26-283788","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849853/000119312526283788/ownership.xml","form_type":"4"}},{"id":725582,"issuer":{"id":3826,"kind":"organization","name":"Stevanato Group S.p.A."},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-26T10:05:44.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":4975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director."}],"balance_after":7250,"source":{"system":"sec-edgar","filing":"0001193125-26-283788","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849853/000119312526283788/ownership.xml","form_type":"4"}},{"id":761335,"issuer":{"id":3869,"kind":"organization","name":"Sotera Health Co"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share (\"Common Stock\")","published_at":"2026-05-27T21:36:23.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":14970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities consist of 14,970 restricted stock units (\"RSUs\") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities consist of 14,970 RSUs and 39,221 shares of Common Stock."}],"balance_after":54191,"source":{"system":"sec-edgar","filing":"0001193125-26-242231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119312526242231/ownership.xml","form_type":"4"}},{"id":945844,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:45:19.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":23372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 35,216 restricted stock units."}],"balance_after":57212,"source":{"system":"sec-edgar","filing":"0001553599-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000155359926000001/primarydocument.xml","form_type":"4"}},{"id":1132959,"issuer":{"id":3869,"kind":"organization","name":"Sotera Health Co"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share (\"Common Stock\")","published_at":"2025-05-27T20:49:27.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":19132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities consist of 19,132 restricted stock units (\"RSUs\") that were granted on May 22, 2025, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities consist of 19,132 RSUs and 20,089 shares of Common Stock."}],"balance_after":39221,"source":{"system":"sec-edgar","filing":"0000950170-25-077814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000095017025077814/ownership.xml","form_type":"4"}},{"id":1309856,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-06T22:48:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":15821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents non-qualified stock option to purchase 15,821 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":15821,"derivative":{"exercise_price":10.76,"exercise_date":"2025-12-31","expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":15821},"source":{"system":"sec-edgar","filing":"0001562180-25-000202","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218025000202/primarydocument.xml","form_type":"4"}},{"id":1309855,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T22:48:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":7435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on December 31, 2025 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,844 restricted stock units."}],"balance_after":33840,"source":{"system":"sec-edgar","filing":"0001562180-25-000202","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218025000202/primarydocument.xml","form_type":"4"}},{"id":1498840,"issuer":{"id":3869,"kind":"organization","name":"Sotera Health Co"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 par value per share (\"Common Stock\")","published_at":"2024-05-29T20:55:03.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":20089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities consist of 20,089 Restricted Stock Units (\"RSUs\") that were granted on May 24, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date."}],"balance_after":20089,"source":{"system":"sec-edgar","filing":"0000950170-24-066037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000095017024066037/ownership.xml","form_type":"4"}},{"id":1687152,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T21:09:29.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents non-qualified stock option to purchase 6,412 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":6412,"derivative":{"exercise_price":27.15,"exercise_date":"2024-12-31","expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":6412},"source":{"system":"sec-edgar","filing":"0001562180-24-000232","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024000232/primarydocument.xml","form_type":"4"}},{"id":1687151,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:09:29.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":2947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on December 31, 2024 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 11,765 restricted stock units."}],"balance_after":26405,"source":{"system":"sec-edgar","filing":"0001562180-24-000232","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218024000232/primarydocument.xml","form_type":"4"}},{"id":1753034,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-31T21:00:54.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":6993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":24339,"source":{"system":"sec-edgar","filing":"0001596783-23-000153","document":"wk-form4_1698786044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678323000153/wk-form4_1698786044.xml","form_type":"4"}},{"id":2066088,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T21:03:54.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":12124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents non-qualified stock option to purchase 12,124 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy."}],"balance_after":12124,"derivative":{"exercise_price":12.86,"exercise_date":"2023-12-31","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":12124},"source":{"system":"sec-edgar","filing":"0001562180-23-000102","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218023000102/primarydocument.xml","form_type":"4"}},{"id":2066087,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:03:54.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":918,"price":12.86,"value":11805.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,310 restricted stock units."}],"balance_after":23458,"source":{"system":"sec-edgar","filing":"0001562180-23-000102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218023000102/primarydocument.xml","form_type":"4"}},{"id":2066086,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:03:54.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":8083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on December 31, 2023 granted pursuant to the Quanterix Corporation Amended and Restated 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,310 restricted stock units."}],"balance_after":22540,"source":{"system":"sec-edgar","filing":"0001562180-23-000102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218023000102/primarydocument.xml","form_type":"4"}},{"id":2129372,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-31T20:49:28.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":4149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2023 annual meeting of shareholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":17346,"source":{"system":"sec-edgar","filing":"0001596783-22-000169","document":"wf-form4_166724935268364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678322000169/wf-form4_166724935268364.xml","form_type":"4"}},{"id":2141930,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T20:04:45.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":1066,"price":10.48,"value":11171.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of the Company's common stock on the Nasdaq Global Market on October 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 13,227 restricted stock units."}],"balance_after":14457,"source":{"system":"sec-edgar","filing":"0001562180-22-007044","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218022007044/primarydocument.xml","form_type":"4"}},{"id":2155066,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T18:31:36.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The equity acquired by the reporting person is the regular, annual grant of restricted stock units (pro-rated to reflect a partial year of service) provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":13197,"source":{"system":"sec-edgar","filing":"0001596783-22-000142","document":"wf-form4_166361228290829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678322000142/wf-form4_166361228290829.xml","form_type":"4"}},{"id":2211435,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T20:07:12.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":164,"price":16.79,"value":2753.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of the Company's common stock on the Nasdaq Global Market on July 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 13,227 restricted stock units."}],"balance_after":13391,"source":{"system":"sec-edgar","filing":"0001562180-22-005558","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218022005558/primarydocument.xml","form_type":"4"}},{"id":2232306,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-14T16:09:26.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":19841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to one-third of the shares on June 6, 2023, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments."}],"balance_after":19841,"derivative":{"exercise_price":16.67,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":19841},"source":{"system":"sec-edgar","filing":"0001562180-22-005091","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218022005091/primarydocument.xml","form_type":"4"}},{"id":2232305,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T16:09:26.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":13227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of shares on each of June 6, 2023, June 6, 2024 and June 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,227 restricted stock units."}],"balance_after":13227,"source":{"system":"sec-edgar","filing":"0001562180-22-005091","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218022005091/primarydocument.xml","form_type":"4"}},{"id":2437449,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-11T23:54:52.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":2472,"price":116.64,"value":288334.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $116.61 to $116.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units."}],"balance_after":33223,"source":{"system":"sec-edgar","filing":"0001596783-22-000014","document":"wf-form4_164194527924124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678322000014/wf-form4_164194527924124.xml","form_type":"4"}},{"id":2622747,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Options to purchase Common Stock","published_at":"2021-07-28T20:26:40.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":5953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest and become exercisable in four equal annual installments beginning on July 26, 2022."}],"balance_after":5953,"derivative":{"exercise_price":113,"expiration_date":"2031-07-26","underlying":"Common Stock","underlying_shares":5953},"source":{"system":"sec-edgar","filing":"0001596783-21-000092","document":"wf-form4_162750398448061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678321000092/wf-form4_162750398448061.xml","form_type":"4"}},{"id":2622746,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Common Stock","published_at":"2021-07-28T20:26:40.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":1151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":35695,"source":{"system":"sec-edgar","filing":"0001596783-21-000092","document":"wf-form4_162750398448061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678321000092/wf-form4_162750398448061.xml","form_type":"4"}},{"id":2910513,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Common Stock","published_at":"2021-01-12T00:12:27.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1100,"price":112.5,"value":123750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units."}],"balance_after":34544,"source":{"system":"sec-edgar","filing":"0001596783-21-000026","document":"wf-form4_161041033160277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678321000026/wf-form4_161041033160277.xml","form_type":"4"}},{"id":2910512,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Common Stock","published_at":"2021-01-12T00:12:27.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1378,"price":112.14,"value":154528.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $111.44 to $112.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units."}],"balance_after":35644,"source":{"system":"sec-edgar","filing":"0001596783-21-000026","document":"wf-form4_161041033160277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678321000026/wf-form4_161041033160277.xml","form_type":"4"}},{"id":2918971,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Common Stock","published_at":"2021-01-06T02:44:59.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":99,"price":104.42,"value":10337.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $104.30 to $104.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units."}],"balance_after":37022,"source":{"system":"sec-edgar","filing":"0001596783-21-000014","document":"wf-form4_160990108479544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678321000014/wf-form4_160990108479544.xml","form_type":"4"}},{"id":3071090,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Options to purchase Common Stock","published_at":"2020-08-03T13:03:34.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":8005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest and become exercisable in four equal annual installments beginning on July 30, 2021."}],"balance_after":8005,"derivative":{"exercise_price":88.1,"expiration_date":"2030-07-30","underlying":"Common Stock","underlying_shares":8005},"source":{"system":"sec-edgar","filing":"0001596783-20-000105","document":"wf-form4_159645979824720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678320000105/wf-form4_159645979824720.xml","form_type":"4"}},{"id":3071089,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Common Stock","published_at":"2020-08-03T13:03:34.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":1476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":37121,"source":{"system":"sec-edgar","filing":"0001596783-20-000105","document":"wf-form4_159645979824720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678320000105/wf-form4_159645979824720.xml","form_type":"4"}},{"id":3177701,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Common Stock","published_at":"2020-04-13T16:19:27.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":359,"price":56.46,"value":20269.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (RSUs) received in lieu of reporting person's receipt of certain other compensation. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on December 31, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":35645,"source":{"system":"sec-edgar","filing":"0001596783-20-000037","document":"wf-form4_158679474913773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678320000037/wf-form4_158679474913773.xml","form_type":"4"}},{"id":3314333,"issuer":{"id":16279,"kind":"organization","name":"Catalent, Inc.","symbol":"CTLT"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. Biologics & CCO"}}],"security":"Common Stock","published_at":"2020-01-09T16:22:11.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":35286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (RSUs) received by the reporting person under the Issuer's omnibus incentive plan in connection with reporting person's election as an executive officer of Issuer. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur as to 25%, 25%, and 50% of the RSUs on each of the first three anniversaries of the grant date, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":35286,"source":{"system":"sec-edgar","filing":"0001596783-20-000004","document":"wf-form4_157858691332565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000159678320000004/wf-form4_157858691332565.xml","form_type":"4"}},{"id":3340581,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T00:47:42.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":11071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the \"Company\") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company."}],"balance_after":39283,"source":{"system":"sec-edgar","filing":"0001192482-19-000545","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248219000545/edgar.xml","form_type":"4"}},{"id":3529215,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-13T14:43:16.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":10888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 9, 2020."}],"balance_after":10888,"derivative":{"exercise_price":8.8,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":10888},"source":{"system":"sec-edgar","filing":"0001192482-19-000254","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248219000254/edgar.xml","form_type":"4"}},{"id":3529214,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T14:43:16.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":7955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 9, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":28212,"source":{"system":"sec-edgar","filing":"0001192482-19-000254","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248219000254/edgar.xml","form_type":"4"}},{"id":3643828,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Stock Options (Right to buy)","published_at":"2019-02-22T00:12:14.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":14280,"price":102.51,"value":1463842.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests in four equal annual installments beginning on February 19, 2020."}],"balance_after":14280,"derivative":{"exercise_price":102.51,"exercise_date":"2020-02-19","expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":14280},"source":{"system":"sec-edgar","filing":"0001562180-19-001219","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218019001219/primarydocument.xml","form_type":"4"}},{"id":3643827,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2019-02-22T00:12:14.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":2099,"price":102.51,"value":215168.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2016 PSUs (PP15) award vesting."}],"balance_after":23692.1476,"source":{"system":"sec-edgar","filing":"0001562180-19-001219","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218019001219/primarydocument.xml","form_type":"4"}},{"id":3849132,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-08-09T14:59:41.000Z","date":"2018-08-07","kind":"exercise","acquired":false,"shares":9458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award vests in 4 equal annual installments beginning on 7/24/2013."}],"balance_after":0,"derivative":{"exercise_price":21.22,"expiration_date":"2022-02-21","underlying":"Common Stock","underlying_shares":9458},"source":{"system":"sec-edgar","filing":"0001562180-18-003539","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018003539/primarydocument.xml","form_type":"4"}},{"id":3849131,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-08-09T14:59:41.000Z","date":"2018-08-07","kind":"exercise","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests in 4 equal annual installments beginning on 2/21/2013."}],"balance_after":20982,"derivative":{"exercise_price":25.145,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001562180-18-003539","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018003539/primarydocument.xml","form_type":"4"}},{"id":3849130,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2018-08-09T14:59:41.000Z","date":"2018-08-07","kind":"sale","acquired":false,"shares":20458,"price":116.23,"value":2377833.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $116.00 to $116.635 inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote."}],"balance_after":21593.1476,"source":{"system":"sec-edgar","filing":"0001562180-18-003539","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018003539/primarydocument.xml","form_type":"4"}},{"id":3849129,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2018-08-09T14:59:41.000Z","date":"2018-08-07","kind":"exercise","acquired":true,"shares":11000,"price":25.145,"value":276595.0,"ownership":{"direct":true},"balance_after":42051.1476,"source":{"system":"sec-edgar","filing":"0001562180-18-003539","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018003539/primarydocument.xml","form_type":"4"}},{"id":3849128,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2018-08-09T14:59:41.000Z","date":"2018-08-07","kind":"exercise","acquired":true,"shares":9458,"price":21.22,"value":200698.76,"ownership":{"direct":true},"balance_after":31051.1476,"source":{"system":"sec-edgar","filing":"0001562180-18-003539","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018003539/primarydocument.xml","form_type":"4"}},{"id":3934268,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-14T20:55:22.000Z","date":"2018-05-12","kind":"exercise","acquired":false,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001192482-18-000208","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248218000208/edgar.xml","form_type":"4"}},{"id":3934267,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T20:55:22.000Z","date":"2018-05-12","kind":"exercise","acquired":true,"shares":13274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":20257,"source":{"system":"sec-edgar","filing":"0001192482-18-000208","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248218000208/edgar.xml","form_type":"4"}},{"id":3938381,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-10T22:54:46.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":8965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the number of stock options acquired on May 4, 2018 as reported on the Form 4 filed on May 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":8965,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":8965},"source":{"system":"sec-edgar","filing":"0001192482-18-000193","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248218000193/edgar.xml","form_type":"4/A","original_submission_date":"2018-05-08"}},{"id":3942228,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-08T21:25:29.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":5742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":5742,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":5742},"source":{"system":"sec-edgar","filing":"0001192482-18-000182","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248218000182/edgar.xml","form_type":"4"}},{"id":3942227,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T21:25:29.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":6183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 4, 2019. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":6983,"source":{"system":"sec-edgar","filing":"0001192482-18-000182","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000119248218000182/edgar.xml","form_type":"4"}},{"id":4042455,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Stock Options (Right to buy)","published_at":"2018-02-22T22:43:07.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":17544,"price":89.64,"value":1572644.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in 4 equal annual installments beginning on 2/20/2019"}],"balance_after":17544,"derivative":{"exercise_price":89.64,"exercise_date":"2019-02-20","expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":17544},"source":{"system":"sec-edgar","filing":"0001562180-18-001152","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018001152/primarydocument.xml","form_type":"4"}},{"id":4056405,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2018-02-15T23:29:38.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":3870,"price":93,"value":359910.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2015 PSU (PP14) award vesting"}],"balance_after":21593.1476,"source":{"system":"sec-edgar","filing":"0001562180-18-001013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018001013/primarydocument.xml","form_type":"4"}},{"id":4115546,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2018-01-03T22:56:10.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":7.484,"price":98.67,"value":738.44628,"ownership":{"direct":true},"balance_after":17723.1476,"source":{"system":"sec-edgar","filing":"0001562180-18-000149","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018000149/primarydocument.xml","form_type":"4"}},{"id":4143515,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-12-05T23:08:03.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":7.4509,"price":99.11,"value":738.458699,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1297.5031,"source":{"system":"sec-edgar","filing":"0001562180-17-003744","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003744/primarydocument.xml","form_type":"4"}},{"id":4155625,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:53.000Z","date":"2017-11-17","kind":"grant","acquired":true,"shares":7.4622,"price":98.96,"value":738.459312,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1290.0522,"source":{"system":"sec-edgar","filing":"0001562180-17-003649","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003649/primarydocument.xml","form_type":"4"}},{"id":4170896,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-11-07T23:24:33.000Z","date":"2017-11-03","kind":"grant","acquired":true,"shares":7.315,"price":100.95,"value":738.44925,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1282.59,"source":{"system":"sec-edgar","filing":"0001562180-17-003504","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003504/primarydocument.xml","form_type":"4"}},{"id":4181567,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-10-24T21:16:46.000Z","date":"2017-10-20","kind":"grant","acquired":true,"shares":7.8693,"price":93.84,"value":738.455112,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1275.275,"source":{"system":"sec-edgar","filing":"0001562180-17-003316","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003316/primarydocument.xml","form_type":"4"}},{"id":4188562,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-10-11T19:19:24.000Z","date":"2017-10-06","kind":"grant","acquired":true,"shares":7.7366,"price":95.45,"value":738.45847,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1267.4057,"source":{"system":"sec-edgar","filing":"0001562180-17-003244","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003244/primarydocument.xml","form_type":"4"}},{"id":4202868,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-09-25T13:33:42.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":7.7561,"price":95.21,"value":738.458281,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1259.6691,"source":{"system":"sec-edgar","filing":"0001562180-17-003003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003003/primarydocument.xml","form_type":"4"}},{"id":4213173,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-09-11T13:09:56.000Z","date":"2017-09-08","kind":"grant","acquired":true,"shares":8.0768,"price":91.43,"value":738.461824,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1251.913,"source":{"system":"sec-edgar","filing":"0001562180-17-002923","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017002923/primarydocument.xml","form_type":"4"}},{"id":4223182,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-08-29T13:43:29.000Z","date":"2017-08-25","kind":"grant","acquired":true,"shares":8.644,"price":85.43,"value":738.45692,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1243.8362,"source":{"system":"sec-edgar","filing":"0001562180-17-002798","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017002798/primarydocument.xml","form_type":"4"}},{"id":4235954,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-08-14T13:05:35.000Z","date":"2017-08-11","kind":"grant","acquired":true,"shares":7.0648,"price":84.93,"value":600.013464,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":1235.1922,"source":{"system":"sec-edgar","filing":"0001562180-17-002663","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017002663/primarydocument.xml","form_type":"4"}},{"id":4317765,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-16T20:29:04.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":13274,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001123292-17-000941","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000112329217000941/edgar.xml","form_type":"4"}},{"id":4399325,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-03-07T14:10:56.000Z","date":"2017-02-17","kind":"tax_withholding","acquired":false,"shares":86,"price":83.13,"value":7149.18,"ownership":{"direct":true},"balance_after":17605.2326,"source":{"system":"sec-edgar","filing":"0001562180-17-001134","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001134/primarydocument.xml","form_type":"4"}},{"id":4434150,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Stock Options (Right to buy)","published_at":"2017-02-22T20:19:14.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":8356,"price":83.47,"value":697475.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in 4 equal annual installments beginning on 2/21/2018."}],"balance_after":27868,"derivative":{"exercise_price":83.47,"exercise_date":"2018-02-21","expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":8356},"source":{"system":"sec-edgar","filing":"0001562180-17-000849","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017000849/primarydocument.xml","form_type":"4"}},{"id":4434149,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Stock Options (Right to buy)","published_at":"2017-02-22T20:19:14.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":19512,"price":83.47,"value":1628666.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in 4 equal annual installments beginning on 2/21/2018."}],"balance_after":19512,"derivative":{"exercise_price":83.47,"exercise_date":"2018-02-21","expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":19512},"source":{"system":"sec-edgar","filing":"0001562180-17-000849","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017000849/primarydocument.xml","form_type":"4"}},{"id":4444377,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-02-16T20:00:49.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":4049,"price":86.93,"value":351979.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares represent the portion of the Performance Share Unit Award granted in 2014 that have vested for period 13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":17691.2326,"source":{"system":"sec-edgar","filing":"0001562180-17-000735","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017000735/primarydocument.xml","form_type":"4"}},{"id":4509183,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2017-01-03T19:21:42.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":8.1611,"price":84.83,"value":692.306113,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1221.8994,"source":{"system":"sec-edgar","filing":"0001562180-17-000064","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017000064/primarydocument.xml","form_type":"4"}},{"id":4516637,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T21:27:24.000Z","date":"2016-12-16","kind":"purchase","acquired":true,"shares":800,"price":6.705,"value":5364.0,"ownership":{"direct":true},"balance_after":800,"source":{"system":"sec-edgar","filing":"0001123292-16-003076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553599/000112329216003076/edgar.xml","form_type":"4"}},{"id":4517980,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-12-19T19:53:47.000Z","date":"2016-12-16","kind":"grant","acquired":true,"shares":8.1804,"price":84.63,"value":692.307252,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1213.7383,"source":{"system":"sec-edgar","filing":"0001562180-16-003838","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218016003838/primarydocument.xml","form_type":"4"}},{"id":4534512,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-12-05T14:08:06.000Z","date":"2016-12-02","kind":"grant","acquired":true,"shares":8.5927,"price":80.57,"value":692.313839,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1205.5579,"source":{"system":"sec-edgar","filing":"0001562180-16-003663","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218016003663/primarydocument.xml","form_type":"4"}},{"id":4548025,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"officer":true,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-11-21T15:05:01.000Z","date":"2016-11-18","kind":"grant","acquired":true,"shares":8.6387,"price":80.14,"value":692.305418,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1196.9652,"source":{"system":"sec-edgar","filing":"0001225208-16-042012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816042012/doc4.xml","form_type":"4"}},{"id":4566189,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"officer":true,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-11-07T16:09:26.000Z","date":"2016-11-04","kind":"grant","acquired":true,"shares":9.183,"price":75.39,"value":692.30637,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1188.3265,"source":{"system":"sec-edgar","filing":"0001225208-16-041221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816041221/doc4.xml","form_type":"4"}},{"id":4575884,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"officer":true,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-10-24T14:56:09.000Z","date":"2016-10-21","kind":"grant","acquired":true,"shares":9.6583,"price":71.68,"value":692.306944,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":1179.1434,"source":{"system":"sec-edgar","filing":"0001225208-16-040697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816040697/doc4.xml","form_type":"4"}},{"id":4582187,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"officer":true,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-10-11T11:12:39.000Z","date":"2016-10-07","kind":"grant","acquired":true,"shares":9.1769,"price":75.44,"value":692.305336,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1167.6807,"source":{"system":"sec-edgar","filing":"0001225208-16-040305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816040305/doc4.xml","form_type":"4"}},{"id":4595729,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"officer":true,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-09-26T16:01:24.000Z","date":"2016-09-23","kind":"grant","acquired":true,"shares":9.5425,"price":72.55,"value":692.308375,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1158.5037,"source":{"system":"sec-edgar","filing":"0001225208-16-039645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816039645/doc4.xml","form_type":"4"}},{"id":4606265,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"officer":true,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-09-12T12:57:01.000Z","date":"2016-09-09","kind":"grant","acquired":true,"shares":8.6333,"price":80.19,"value":692.304327,"ownership":{"direct":false,"nature":"Non-Qualified Deferred Compensation Plan"},"balance_after":1148.9612,"source":{"system":"sec-edgar","filing":"0001225208-16-039215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816039215/doc4.xml","form_type":"4"}},{"id":4610199,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":35170,"kind":"person","name":"Flynn Karen","position":1,"cik":"0001553599","reported_name":"Flynn Karen","relationship":{"officer":true,"officer_title":"Sr VP & Chief Commercial Offic"}}],"security":"Common Stock","published_at":"2016-09-07T13:40:10.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":14581,"price":83.28,"value":1214305.68,"ownership":{"direct":true},"balance_after":13512.549,"source":{"system":"sec-edgar","filing":"0001225208-16-038910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816038910/doc4.xml","form_type":"4"}}]}